About Cresanto Global Limited 
Cresanto Global Limited
Micro Cap
Pharmaceuticals & Biotechnology
Raymed Labs Ltd is engaged in the manufacturing of pharmaceutical products and injectables.The product range of the company includes RAMPICILLIN - Ampicillin, a semisynthetic penicillin.RAMPICLOX - Equal quantities of Ampicillin and Cloxacillin.RAMPIMOX - Equal quantities of Amoxycillin and Cloxacillin.RAMYKACIN - Amikacin Sulphate.OXYTETRACYCLINE - The most common Antibiotic in Veterinary Practice.RAMYFENAC-Diclofenac Sodium. It is a potent non steroidal Anti-inflammatory, Analgesic & Antipyretic for human use.RAMAMINE- Chlorpheniramine Maleate. The most potent & effective Anti-histaminic for veterinary use.RAMYDEX-Dexamethasone Sodium Phosphate. Anti-inflammatory, Anti-allergic, Gluco-corticoid adjuvant with Antibiotic therapy.RAMYCIN-Gentamycin Sulphate.RAMYPINE - Atropin Sulphate. The drug has anticholenergic effect in veterinary use.RAMYCHLOR - Chloramphenicol.REALOPAR - Paracetamol.RAYVIL - Pheniramine Maleate.RAMALGIN-P - Phenylbutazone and Analgin with Lignocaine: A unique combination of highly effective analgesic, antispasmodic, anti-inflammatory & Antipyretic for veterinary use.RAMYSCAB - Sulphur with Benzyl Benzoate in Lidocaine base: An ideal treatment of Scabies & other dermal problems in animals.RAMYVIT PLEX - Vitamin B1, Vitamin B2, Vitamin B3, Vitamin B12 with Liver Extract: crude injection and ideal treatment of Scabies & other dermal problems in animals.
Company Coordinates 
Company Details
103 Emperor 1 Sector 93A, Supertech Emerald Court Noida Uttar Pradesh : 201304
Registrar Details
Beetal Financial & Computer Services (P) Ltd , Beetal House , 99 Mandangir, 3rd Floor, Behind Local Shopping Centre, Near Dada Harsukhdas Mandir, New Delhi
Capital Structure 
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
No Details Available.
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Nishant N Bajaj (9.05%)
Highest Public shareholder
Amzel Limited (7.02%)
Individual Investors Holdings
44.15%
Management
Designation
Remuneration
Diwakar Agrawal
Company Secretary & Compliance Officer
0
Raw Materials Dashboard 
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Dashboard 
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Revenue and Profits:
Net Sales:
(Quarterly Results - Dec 2025)
Net Profit:
0 Cr
Pharmaceuticals & Biotechnology
INR 2 Cr (Micro Cap)
NA (Loss Making)
33
0.00%
0.00
7.48%
-0.75






